Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.627ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.627ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.627ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.627NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.519ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.519ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.519ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.519NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.514ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.514ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.514ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.514NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GT.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GT.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.87ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.87ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.87ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.87NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAPORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAPENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAPNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.4.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.4.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.6.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.6.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.47.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.47.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.47.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.47.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBF.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DN.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used